EN
HI
Suven Life Sciences Chart
Suven Life Sciences Share Key Metrics
Volume
5.42 L
Market Cap
5568.46 CR
LTQ@LTP
4@211.15
ATP
212.14
Var Margin
25.82 %
Circuit Range
165.24-247.86
Delivery %
51.9 %
Value
11.50 CR
ASM/GSM
No
Market Lot
1
Summary
Suven Life Sciences share price is ₹211.15 as of 17 May, 2026. The stock Suven Life Sciences intraday movement has stayed between ₹202.31 and ₹217.00, while on a 52-week basis,Suven Life Sciences price 52 week high is ₹299.99 & its 52 week low is ₹124.11.
In terms of trading activity, Suven Life Sciences has recorded a volume of 541885 shares, The Suven Life Sciences has a market cap of ₹263720583 CR. The stock’s Average Traded Price (ATP) stands at ₹212.14, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 4 @ ₹211.15.
Suven Life Sciences operates within a circuit range of ₹165.24 – ₹247.86, with a Value of ₹11.50 CR. The Delivery Percentage for the day is 51.9%. Additionally, Suven Life Sciences currently falls under the No framework, and trades with a market lot size of 1.
Suven Life Sciences Fundamentals
View MoreP/E Ratio
0
P/B Ratio
9.2
Div. Yield
0
Sector P/E
67.24
Sector P/B
3.49
Sec. Div. Yield
0.56
Suven Life Sciences Resistance and Support
Pivot 208.66
Resistance
First Resistance
212.72
Second Resistance
218.9
Third Resistance
222.96
Support
First Support
202.48
Second Support
198.42
Third Support
192.24
Suven Life Sciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-13 | Audited Results |
| 2026-01-29 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-05-13 | Audited Results & Preferential issue |
| 2025-01-24 | Quarterly Results |
Suven Life Sciences News
Suven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Suven Life Sciences announced the receipt of a Monitoring Agency Report from CRISIL Ratings. The report confirms that proceeds from the preferential issue have been fully utilized as per the disclosures for the quarter ended March 31, 2026, with no deviations found.
May 14 2026 12:05:00
Suven Life Sciences Ltd - 530239 - Board Meeting Outcome for Outcome Of Board Meeting Of Suven Life Sciences Limited Held On May 13, 2026
Suven Life Sciences Board approved FY26 consolidated financial results, reporting a net loss of ₹2,763.44 million and revenue of ₹210.45 million, up 19.89% YoY. The company also announced its 37th Annual General Meeting for August 25, 2026, and highlighted progress in its clinical pipeline, including 76% enrollment for SUVN-502 in Phase 3.
May 13 2026 13:05:00
Read More
About Suven Life Sciences
NSE : 11233
BSE : 530239
ISIN : INE495B01038
Suven Pharmaceuticals Limited was promoted in 1989 byMr.Jasti Venkateswarlu and Mrs. Jasti Sudha Rani for themanufacture of bulk drugs and drug intermediates. TheCompany was incorporated as a Private Limited Company on9th March 1989 in the state of Andhra Pradesh.Subsequently on 4th January 1995 it was converted into aPublic Limited Company in terms of special resolution dated25.11.94 U/s. 31(1)/44 of Companies Act.
Suven Life Sciences Management
| Name | Position |
|---|---|
| Venkateswarlu Jasti | Chairman & Managing Director |
| Seyed E Hasnain | Non Executive Director |
Suven Life Sciences Similar Stocks
Sudeep Pharma Ltd.
648.95
-23.55 (3.50%)
Aarti Pharmalabs Ltd.
711.75
-7.50 (1.04%)
FDC Ltd.
366.15
-2.95 (0.80%)
Kovai Medical Center & Hospital Ltd.
5427.50
62.50 (1.16%)
Nephrocare Health Services Ltd.
643.95
60.65 (10.40%)
Supriya Lifescience Ltd.
688.55
3.30 (0.48%)
Innova Captab Ltd.
858.30
-13.60 (1.56%)
Senores Pharmaceuticals Ltd.
1050.35
95.70 (10.02%)
Artemis Medicare Services Ltd.
279.80
2.38 (0.86%)
Advanced Enzyme Technologies Ltd.
363.75
-1.50 (0.41%)
Suven Life Sciences FAQs
The Buying Price of Suven Life Sciences share is 211.15 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Suven Life Sciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Suven Life Sciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Suven Life Sciences shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Suven Life Sciences shares is 9.2. Useful to assess the stock's value relative to its book value.
To assess Suven Life Sciences’s valuation compare Sector P/E, P/B which are 67.24 & 3.49 with sector averages, along with growth rates and financial metrics.
The Market Cap of Suven Life Sciences is 5568.46 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Suven Life Sciences share price is 299.99 & 124.11. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Suven Life Sciences belongs to the Healthcare sector.
